A Randomized Study to Evaluate the Safety and Efficacy of Loading Dose of Bondronat Versus Standard Dose of Bondronat in Patients With Lung Cancer and Skeletal Metastasis Experiencing Moderate to Severe Pain

Trial Profile

A Randomized Study to Evaluate the Safety and Efficacy of Loading Dose of Bondronat Versus Standard Dose of Bondronat in Patients With Lung Cancer and Skeletal Metastasis Experiencing Moderate to Severe Pain

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 19 Feb 2016

At a glance

  • Drugs Ibandronic acid (Primary)
  • Indications Cancer metastases; Lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jun 2008 Status change from initiated to discontinued according to clinicaltrials.gov, due to difficulty recruiting suitable patients.
    • 20 Sep 2007 Updated start date fromo NCT.
    • 12 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top